| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 14.93B | 10.90B | 26.15B | 20.91B | 11.17B |
| Gross Profit | -88.80M | -199.30M | -136.90M | 421.46M | 90.66M |
| EBITDA | -103.20M | -135.10M | 72.80M | 423.19M | 395.12M |
| Net Income | -149.30M | -87.40M | -150.50M | 285.90M | 329.40M |
Balance Sheet | |||||
| Total Assets | 1.30B | 1.43B | 1.70B | 2.17B | 1.74B |
| Cash, Cash Equivalents and Short-Term Investments | 441.60M | 517.70M | 832.10M | 907.08M | 642.57M |
| Total Debt | 21.40M | 23.90M | 22.00M | 29.10M | 30.98M |
| Total Liabilities | 316.30M | 364.70M | 508.30M | 843.79M | 634.87M |
| Stockholders Equity | 985.60M | 1.06B | 1.19B | 1.32B | 1.10B |
Cash Flow | |||||
| Free Cash Flow | -95.30M | -264.40M | -65.10M | 330.06M | 95.18M |
| Operating Cash Flow | -65.00M | -208.00M | 11.30M | 538.43M | 103.15M |
| Investing Cash Flow | -25.80M | -77.80M | -77.00M | -97.99M | -88.35M |
| Financing Cash Flow | -7.40M | -8.30M | -16.90M | -4.53M | -150.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | HK$870.12M | 4.58 | 103.07% | ― | 0.41% | 83.35% | |
54 Neutral | HK$456.00M | 7.94 | 1.07% | ― | 7.89% | ― | |
50 Neutral | HK$2.55B | -20.13 | -17.10% | ― | -73.03% | -241.72% | |
45 Neutral | HK$340.93M | -2.28 | -14.90% | ― | 36.99% | -71.00% | |
38 Underperform | HK$44.24M | -0.11 | -177.54% | ― | -26.77% | -69.57% |